Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.
Global Cancer Consortium
BioSante Announces Positive Data on Leukemia Drug
BioSante Pharmaceuticals may be known for its sexual health products such as LibiGel, but the Illinois-based company is also developing a novel immunotherapy vaccine to treat cancer.
Translating Data Into Better Healthcare
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
IMUC: Immunotherapy On Multiple Fronts
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
NeoMatrix: A “Pap Smear for Breast Cancer”
Neomatrix of Irvine, Calif., has developed a fully automated, non-invasive device to assess a patient’s risk of developing breast cancer.
Quantum Immunologics’ Alternative to Chemotherapy
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
Nanoscale Imaging and Sensing Technology, Drug Safety profile, Cancer Analysis
Imaging, Oncology, Drug Delivery. This company has developed an unprecedented technological platform to enable imaging at the smallest biological scale, the cell. The company’s technology utilizes combinatorial light and sound input to […]
An Amplifier for Diagnostic Tests
Sword Diagnostics of Illinois has developed a “next-generation” system to increase the sensitivity (and therefore accuracy) of diagnostic tests.
